Company intelligence / Profile preview

G2E

Seoul, South Koreaglobalgamingexpo.com ↗

Ownership: Private
Development stage: Other

Overview

G2E develops and provides healthcare products including u-healthcare external insulin injectors and mobile hospitals. Their focus is on safe, precise use of medical devices for the healthcare industry. The company has raised $17.52M to date and continues to expand its digital health offerings.

Therapeutic areas: Endocrinology
Modalities: Device (external insulin injectors)
Industry: Therapeutic Medical Devices

Beyond the preview

Go deeper on G2E.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on G2E.

Explore the full profile